JP2015519564A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015519564A5 JP2015519564A5 JP2015511614A JP2015511614A JP2015519564A5 JP 2015519564 A5 JP2015519564 A5 JP 2015519564A5 JP 2015511614 A JP2015511614 A JP 2015511614A JP 2015511614 A JP2015511614 A JP 2015511614A JP 2015519564 A5 JP2015519564 A5 JP 2015519564A5
- Authority
- JP
- Japan
- Prior art keywords
- eclampsia
- level
- markers
- marker
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000011461 pre-eclampsia Diseases 0.000 claims 23
- 238000000034 method Methods 0.000 claims 16
- 239000003550 marker Substances 0.000 claims 9
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 238000004458 analytical method Methods 0.000 claims 3
- 238000001514 detection method Methods 0.000 claims 3
- 108091007507 ADAM12 Proteins 0.000 claims 2
- 102100031112 Disintegrin and metalloproteinase domain-containing protein 12 Human genes 0.000 claims 2
- 238000002965 ELISA Methods 0.000 claims 2
- 108010082093 Placenta Growth Factor Proteins 0.000 claims 2
- 102100035194 Placenta growth factor Human genes 0.000 claims 2
- 238000003745 diagnosis Methods 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 208000004930 Fatty Liver Diseases 0.000 claims 1
- 206010019708 Hepatic steatosis Diseases 0.000 claims 1
- 102100033226 Pikachurin Human genes 0.000 claims 1
- 101710178799 Pikachurin Proteins 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 238000012790 confirmation Methods 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 208000010706 fatty liver disease Diseases 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 230000035935 pregnancy Effects 0.000 claims 1
- 238000003118 sandwich ELISA Methods 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 231100000240 steatosis hepatitis Toxicity 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 230000036266 weeks of gestation Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261644254P | 2012-05-08 | 2012-05-08 | |
| US61/644,254 | 2012-05-08 | ||
| US201261731640P | 2012-11-30 | 2012-11-30 | |
| US61/731,640 | 2012-11-30 | ||
| PCT/US2013/039918 WO2013169751A1 (en) | 2012-05-08 | 2013-05-07 | Methods and compositions for providing a preeclampsia assessment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015519564A JP2015519564A (ja) | 2015-07-09 |
| JP2015519564A5 true JP2015519564A5 (enExample) | 2016-06-23 |
Family
ID=49551212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015511614A Pending JP2015519564A (ja) | 2012-05-08 | 2013-05-07 | 子癇前症評価を提供するための方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20150099655A1 (enExample) |
| EP (1) | EP2847354A4 (enExample) |
| JP (1) | JP2015519564A (enExample) |
| CN (1) | CN104487593A (enExample) |
| GB (1) | GB2515983A (enExample) |
| HK (2) | HK1206071A1 (enExample) |
| WO (1) | WO2013169751A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014160237A2 (en) * | 2013-03-14 | 2014-10-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of prognosing preeclampsia |
| WO2016019176A1 (en) * | 2014-07-30 | 2016-02-04 | Matthew Cooper | Methods and compositions for diagnosing, prognosing, and confirming preeclampsia |
| CN107367618B (zh) * | 2014-10-10 | 2020-02-14 | 韦恩州立大学 | 与胎儿绒毛外滋养层细胞测定有关的方法和组合物 |
| EP3259600B1 (en) * | 2015-02-18 | 2024-07-24 | MirZyme Therapeutics Limited | Diagnostic assay and treatment for preeclampsia |
| CA2977458A1 (en) * | 2015-03-16 | 2016-09-22 | A1M Pharma Ab | Biomarkers for preeclampsia |
| WO2017075027A1 (en) * | 2015-10-26 | 2017-05-04 | Brigham Young University | Serum lipid biomarkers of preeclampsia |
| JP7080176B2 (ja) * | 2016-02-29 | 2022-06-03 | エフ．ホフマン－ラ ロシュ アーゲー | 子癇前症におけるマーカーとしてのｉｇｆｂｐ－７ |
| EP3458861A4 (en) * | 2016-05-17 | 2019-12-11 | LDX Prognostics Limited Co. | METHOD AND COMPOSITIONS FOR ASSESSING PRECLAMPSY |
| KR20240100488A (ko) | 2016-06-07 | 2024-07-01 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 세균성 감염 및 바이러스성 감염의 진단 방법 |
| GB201702792D0 (en) | 2017-02-21 | 2017-04-05 | Queens Univ Of Belfast | A new biomarker for preeclampsia |
| US20200264188A1 (en) | 2017-09-13 | 2020-08-20 | Progenity, Inc. | Preeclampsia biomarkers and related systems and methods |
| RU2691114C1 (ru) * | 2018-03-20 | 2019-06-11 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ прогнозирования развития преэклампсии в поздние сроки беременности |
| WO2020117184A1 (en) * | 2018-12-02 | 2020-06-11 | Binhai Industrial Technology Research Institute Of Zhejiang University | Methods and compositions for providing a preeclampsia assessment by proteomics |
| CN110305954B (zh) * | 2019-07-19 | 2022-10-04 | 广州市达瑞生物技术股份有限公司 | 一种早期准确检测先兆子痫的预测模型 |
| EP4070113A4 (en) | 2019-12-04 | 2023-12-20 | Biora Therapeutics, Inc. | ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS |
| KR102302742B1 (ko) * | 2019-12-31 | 2021-09-15 | 의료법인 성광의료재단 | 임신중독증 진단용 바이오마커 조성물 및 이의 용도 |
| US12426782B2 (en) | 2020-11-06 | 2025-09-30 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and temporal alignment methods for evaluation of gestational age and time to delivery |
| CN112946283B (zh) * | 2021-01-29 | 2022-11-29 | 暨南大学 | 定量a2m的产品在制备子痫前期诊断工具中的应用 |
| WO2022186821A1 (en) * | 2021-03-02 | 2022-09-09 | Mprobe Inc., | Methods and compositions for providing a preeclampsia assessment using leptin and ceramide |
| CN113223714B (zh) * | 2021-05-11 | 2022-07-05 | 吉林大学 | 一种用于预测子痫前期风险的基因组合、子痫前期风险预测模型及其构建方法 |
| CN115308423B (zh) * | 2022-10-10 | 2023-02-10 | 天津云检医疗器械有限公司 | 用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法 |
| EP4636095A1 (en) * | 2022-12-16 | 2025-10-22 | BGI Genomics Co., Limited | Preeclampsia biomarker and use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5009811B2 (ja) * | 2004-12-21 | 2012-08-22 | イェール ユニバーシティ | 子癇前症の検出 |
| CA3147058A1 (en) * | 2005-03-18 | 2006-09-21 | The Chinese University Of Hong Kong | Markers for prenatal diagnosis, monitoring or predicting preeclampsia |
| EP1946121A2 (en) * | 2005-10-27 | 2008-07-23 | Yale University, Inc. | Urinary proteomic biomarker patterns in preeclampsia |
| US20080071151A1 (en) * | 2006-06-30 | 2008-03-20 | Sogin David C | Method and Apparatus for Diagnosing Pre-eclampsia |
| US20080233583A1 (en) * | 2007-02-20 | 2008-09-25 | Regents Of The University Of California | Biomarkers for preeclampsia |
| US20090068683A1 (en) * | 2007-06-11 | 2009-03-12 | Mayo Foundation For Medical Education And Research | Markers for preeclampsia |
| WO2009108073A1 (en) * | 2008-02-28 | 2009-09-03 | Auckland Uniservices Limited | Biomarkers for prediction of preeclampsia and/or cardiovascular disease |
| CA2795776A1 (en) * | 2010-04-06 | 2011-10-13 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Circulating biomarkers for disease |
| JP2013524251A (ja) * | 2010-04-13 | 2013-06-17 | プロノタ エヌ．ヴェ． | 妊娠高血圧疾患のバイオマーカー |
| CN103415769B (zh) * | 2010-12-06 | 2017-04-12 | 迈卡蒂斯股份有限公司 | 用于妊娠性高血压疾病的生物标志物和参数 |
| EP2766726A1 (en) * | 2011-10-14 | 2014-08-20 | Aarhus Universitet | Diagnostic and prognostic use of prombp-complexes |
| WO2014160237A2 (en) * | 2013-03-14 | 2014-10-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of prognosing preeclampsia |
-
2013
- 2013-05-07 JP JP2015511614A patent/JP2015519564A/ja active Pending
- 2013-05-07 GB GB1420279.0A patent/GB2515983A/en not_active Withdrawn
- 2013-05-07 CN CN201380036211.4A patent/CN104487593A/zh active Pending
- 2013-05-07 US US14/396,721 patent/US20150099655A1/en not_active Abandoned
- 2013-05-07 EP EP13788066.2A patent/EP2847354A4/en not_active Withdrawn
- 2013-05-07 HK HK15106500.3A patent/HK1206071A1/xx unknown
- 2013-05-07 WO PCT/US2013/039918 patent/WO2013169751A1/en not_active Ceased
- 2013-05-07 HK HK15107134.5A patent/HK1206790A1/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015519564A5 (enExample) | ||
| Mueller et al. | The Presage® ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2 | |
| JP2019516966A5 (enExample) | ||
| JP2014508298A5 (enExample) | ||
| WO2007117444A3 (en) | Protein detection by aptamers | |
| RU2017144232A (ru) | Пары биологических маркеров для предсказания преждевременных родов | |
| RU2476887C2 (ru) | Способ прогнозирования развития осложнений у больных внебольничной пневмонией | |
| RU2015136673A (ru) | Биомаркеры сахарного диабета 2 типа и их применение | |
| JP2015514227A5 (enExample) | ||
| WO2013132347A3 (en) | Improved elisa immunoassay for calprotectin | |
| WO2014074835A3 (en) | Antibody compositions and immunoassay methods to detect isoforms of anti-mullerian hormone | |
| RU2016137685A (ru) | Способ диагностики туберкулеза | |
| Cheng et al. | New markers in pneumonia | |
| BR112014029233A8 (pt) | método para diagnosticar se um indivíduo grávido não está em risco, usos de pelo menos um dos biomarcadores sfit-1, endoglina e pigf, dispositivo, kit, método de gestão de um indivíduo, sistema e método para estabelecer um auxílio | |
| CN102224422A (zh) | 使用pigf-2和pigf-3标志物确定先兆子痫风险的方法 | |
| EP3915584A3 (en) | Immunoassay of s-adenosylmethionine using analogs thereof and personalized therapeutics | |
| WO2014140974A3 (en) | System and method for determining risk of diabetes based on biochemical marker analysis | |
| JP2013504766A5 (enExample) | ||
| Dieplinger et al. | Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit—the Linz Intensive Care Unit (LICU) study | |
| Singh et al. | Does microalbuminuria at mid‐pregnancy predict development of subsequent pre‐eclampsia? | |
| Huang et al. | Urinary spot albumin: creatinine ratio for documenting proteinuria in women with preeclampsia | |
| CN204479594U (zh) | 基于生物标志物的糖尿病肾病早期检测试剂盒 | |
| JP2017524933A5 (enExample) | ||
| Shreya et al. | Comparison of spot urine protein-creatinine ratio with 24-hour urine protein excretion in women with preeclampsia | |
| WO2018091665A1 (en) | Risk assessment for neonatal chronic lung disease |